Federal Register / Vol. 62, No. 161 / Wednesday, August 20, 1997 / Notices 44285

Ballroom at the Radisson Hotel City

Centre. The Farmworker Hearing is

scheduled for Saturday, September 13

from 9 a.m. to 5 p.m. in the Carter

Chapel at Indiana Wesleyan University,

4201 S. Washington St., Marion, Indiana

46953.

The Council meeting is being held in

conjunction with the 1997 Midwest

Farmworker Stream Forum, September

11–14, 1997. The Stream Forum also

will take place at the Radisson Hotel

City Centre, Indianapolis, IN.

Anyone requiring information

regarding the subject Council should

contact Susan Hagler, Migrant Health

Program, staff support to the National

Advisory Council on Migrant Health,

Bureau of Primary Health Care, Health

Resources and Services Administration,

4350 East West Highway, Room 7–5A1,

Bethesda, Maryland 20814, Telephone

301/594–4302.

Agenda items are subject to change as

priorities indicate.

Dated: August 14, 1997.

Jane Harrison,

Acting Director, Division of Policy Review

and Coordination.

[FR Doc. 97–22027 Filed 8–19–97; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Notice of Meeting of the

Fogarty International Center Advisory

Board

Pursuant to Pub. L. 92–463, as

amended, notice is hereby given of the

thirty-seventh meeting of the Fogarty

International Center (FIC) Advisory

Board, September 23, 1997, in the

Lawton Chiles International House

(Building 16) at the National Institutes

of Health. The Research Awards

Subcommittee will meet on September

22 in the FIC Conference Room,

Building 31, Room B2C07, from 1:00

p.m. to approximately 4:00 p.m., and

will be closed to the public.

The meeting of the Board will be open

to the public from 8:30 a.m. to

approximately 12:00 noon.

The agenda will include a report by

the Director, FIC; a report on the status

of the planning and implementation

process of the Government Performance

and Results Act at the NIH; a

presentation on the results of the

evaluation of the International

Cooperative Biodiversity Groups

Programs; a presentation on the Institute

of Medicine’s Board on International

Health Report ‘‘America’s Vital Interest

in Global Health;’’ and an update on FIC

long-range planning activities.

In accordance with the provisions of

sections 552b(c)(4) and 552(c)(6), Title

5, United States Code and section 10(d)

of Pub. L. 92–463, as amended, the

entire meeting of the Research Awards

Subcommittee on September 22 will be

closed to the public from 1:00 p.m. to

approximately 4:00 p.m., and the Board

meeting on September 23 will be closed

to the public from 1:00 p.m. to

adjournment for the review of

applications for awards under the

Senior International Fellowship

Program; and the Fogarty International

Research Collaboration Awards and

HIV, AIDS and Related Illnesses

Collaboration Awards.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Cohen at least 2 weeks in

advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.989, Senior International

Fellowship Awards Program, and 93.934,

Fogarty International Research Collaboration

Award.)

Dated: August 12, 1997.

Laverne Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–22032 Filed 8–19–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the National Institute

of General Medical Sciences meeting:

Committee Name: Biomedical Research &

Research Training Committee (BRRT)

Subcommittees—A, B, and C.

Date: November 6–7, 1997.

Time: 08:30 a.m. until 5:00 p.m.

Place: Hyatt Regency Hotel, One Bethesda

Metro Center, Bethesda, MD 20814.

Contact Person: Carol Latker, Ph.D., Irene

Glowinski, Ph.D., Arthur Zachary, Ph.D.,

Office of Scientific Review, Scientific Review

Administrator, NIGMS, 45 Center Drive,

Room 1AS–19D, Bethesda, MD 20892–6200.

Telephone: 301–594–3663.

Purpose: To review pre and post doctoral

service applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6). Title 5 U.S.C. The

discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862, Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].)

Dated: August 12, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–22031 Filed 8–19–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Prospective Grant of Exclusive

License: Biomedical Uses of

Topoisomerase I Inhibitors Including

Camptothecin and Derivatives for

Retroviral Applications Including

Human Immunodeficiency Virus (HIV)

AGENCY: National Institutes of Health,

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: This is notice in accordance

with 15 U.S.C. 209(c)(1) and 37 CFR

404.7(a)(1)(i) that the National Institutes

of Health (NIH), Department of Health

and Human Services, is contemplating

the grant of a domestic exclusive license

to practice the inventions embodied in

the patents and patent applications

referred to below to Virologix

Corporation of New York, New York.

The patent rights in these inventions

have been assigned to the government of

the United States of America. The

patents and patent applications to be

licensed are: